HIF1A and head and neck squamous cell carcinoma: Moreover, GRIM-19 inhibits the aerobic glycolysis, cell proliferation, and tumorigenesis of head and neck squamous cell carcinoma by inhibiting HIF-1α/STAT3 [32].